Valuation (10%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -1.76 | -39.04 |
PEG Ratio (TTM) | -0.02 | -2.14 |
P/S Ratio (TTM) | N/A | 51.80 |
P/B Ratio (TTM) | 1.26 | 16.01 |
P/FCF Ratio (TTM) | N/A | -212.22 |
Price to 5YR AVG Earnings Ratio | N/A | -39.32 |
Price to 5YR AVG FCF Ratio | N/A | -27.27 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -51.81% | 40.55% |
ROE (TTM) | -84.78% | -488.55% |
Net Profit Margin (TTM) | N/A | -358.55% |
ROIC 5YR AVG | N/A | 791.01% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -283.88% | N/A | N/A |
Revenue | N/A | N/A | N/A |
Net Income | -316.08% | N/A | N/A |
Cash Flow | -5.11% | N/A | N/A |
Health (21%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.25 | 2.52 |
Quick Ratio (TTM) | 0.23 | 44.73 |
D/E Ratio (TTM) | N/A | 0.17 |
Interest Coverage (TTM) | 0.86 | 3.61 |
Piotroski F-Score | N/A | 3 |
Altman Z-Score | 35.68 | 21.93 |
LTL to 5YR AVG FCF | N/A | -0.68 |
Shares Outstanding Growth 5YR AVG | N/A | 488.34% |